Proendocrine genes coordinate the pancreatic islet differentiation program in vitro

Area of Science:

• Developmental Biology
• Endocrinology
• Molecular Biology

Background:

• Neurogenin3 (Ngn3) is a key transcription factor specifying endocrine cell fate in the developing pancreas.
• NeuroD1, a downstream target of Ngn3, is crucial for maintaining the endocrine differentiation program.

Purpose of the Study:

• To develop an in vitro model of Ngn3-dependent pancreatic islet differentiation.
• To investigate the distinct roles of Ngn3 and NeuroD1 in activating the islet differentiation program.
• To identify novel genes involved in endocrine pancreas development and function.

Main Methods:

• Utilized an adenovirus expressing Ngn3 to infect pancreatic duct cell lines, establishing an in vitro differentiation model.
• Analyzed gene expression changes induced by Ngn3 and NeuroD1, including early and late differentiation markers.
• Employed microarray analysis to identify previously uncharacterized Ngn3-induced genes.

Main Results:

• Both Ngn3 and NeuroD1 activated the islet differentiation program, inducing genes essential for early and mature islet cell function.
• Gene induction by Ngn3 and NeuroD1 involved alterations in local chromatin structure, exemplified by the insulin1 gene.
• Ngn3 and NeuroD1 activated distinct, non-overlapping subsets of genes, highlighting their specific roles in endocrine pancreas development.

Conclusions:

• Ngn3 initiates islet differentiation, while NeuroD1 maintains the program, with each factor having unique gene activation profiles.
• Identified novel Ngn3-regulated genes with potential significance for islet development and function.
• The developed in vitro model serves as a platform for testing strategies to generate pancreatic islet cells for diabetes therapy.